CART19 cells effects in patients with relapsed/refractory acute lymphoblastic leukemia and non-Hodgkin lymphoma.

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-510815-30-00

Acronym

UHKT-CAR19-01

Enrollment

Registered

2024-07-23

Start date

2021-06-02

Completion date

Unknown

Last updated

2025-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Relapsed/refractory CD19+ Acute Lymphoblastic Leukaemia and Non-Hodgkin Lymphoma

None listed

Sex/Gender

All

Age

18 Years to No maximum

Czechia

None listed

Source: EU CTIS · Data processed: Feb 4, 2026